Immucell Corp (ICCC) Reports Q2 Loss of $0.09
Tweet
Share
E-mailGet Alerts ICCC Hot Sheet
Join SI Premium – FREE
Immucell Corp (NASDAQ: ICCC) reported Q2 EPS of ($0.09), versus ($0.02) reported last year. Revenue for the quarter came in at $1.25 million, versus $1.08 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Immucell Corp (ICCC) Reports Q2 EPS of $0.20
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
